Intellectual Property
Apple-Masimo patent battle heads to jury over what counts as a 'patient monitor'
With hundreds of millions of dollars at stake, jurors must decide if Apple misused Masimo's pulse-oximetry technology in the Apple Watch -- and whether a smartwatch can ever qualify as a medical patient monitor under patent law.
SANTA ANA -- A federal jury is weighing sharply conflicting narratives in a long-running patent fight between Apple Inc. and Masimo Corp., after lawyers delivered closing arguments this week in a case that could reshape how courts assess intellectual property claims involving consumer wearables with quasi-medical functions.
Masimo alleges Apple misappropriated its pulse-oximetry technology and incorporated it into Apple Watch models sold from 2020 to 2022. The parties offered dama...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In